Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of Single Oral TPN171H in Elderly Subjects
NCT06090136Phase 1Completed
- Sponsor
- Vigonvita Life Sciences
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of TPN171H in erectile dysfunction (ED), sponsored by Vigonvita Life Sciences. Primary endpoints: Adverse events, Pharmacokinetic parameter of TPN171H: Tmax and 10 more. Started Sep 2020; status: completed.
02
Drugs
TPN171H
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06090136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06090136.